Adare Pharmaceuticals:Overcoming complex formulation challenges. Adding value to your products.

Article

Have your medicines reached their full potential? Adare has the ability to solve complex formulation challenges and create or extend IP protection for new or existing medicines.

 

Have your medicines reached their full potential? Adare has the ability to solve complex formulation challenges and create or extend IP protection for new or existing medicines.

 

 

Taste Masking and ODTs

Several factors, such as bitter taste, administration difficulty, dosing frequency, and inconvenience, contribute to the lack of patient acceptance and adherence to a prescribed therapy. Microcaps®, AdvaTab®, and Liquitard® technologies address these complex formulation challenges by improving taste, promoting ease of administration, and adding convenience.

 

Customized Drug Release

To optimize the therapeutic performance of drugs, customized drug-release profiles can be combined to improve efficacy, enhance safety, and reduce dosing frequency.

Diffucaps®, Diffutab®, Eurand Minitabs®, and Orbexa™ proprietary technologies can create novel customized-release profiles that optimize the therapeutic performance of pharmaceutical products.

 

Bioavailability Enhancement

The bioavailability of a drug is strongly dependent on its solubility in the aqueous environment of the GI tract.

Biorise™ and Diffucaps® (Solid-Solution or Solid-Dispersion) enhance the bioavailability of drugs that are poorly soluble at physiological pH levels.

 

With these proprietary technologies, Adare can help you add further value to your products, while meeting patients’ unique needs. To learn more about our proprietary technologies or partnership opportunities, contact Lisa.Miller@adarepharma.com or visit www.AdarePharma.com.

 

©2015 Adare Pharmaceuticals, Inc.

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content